Your browser doesn't support javascript.
loading
Specific targeting of IL-1ß activity to CD8+ T cells allows for safe use as a vaccine adjuvant.
Van Den Eeckhout, Bram; Van Hoecke, Lien; Burg, Elianne; Van Lint, Sandra; Peelman, Frank; Kley, Niko; Uzé, Gilles; Saelens, Xavier; Tavernier, Jan; Gerlo, Sarah.
Afiliación
  • Van Den Eeckhout B; VIB-UGent Center for Medical Biotechnology, 9052 Ghent, Belgium.
  • Van Hoecke L; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Burg E; VIB-UGent Center for Medical Biotechnology, 9052 Ghent, Belgium.
  • Van Lint S; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium.
  • Peelman F; VIB-UGent Center for Medical Biotechnology, 9052 Ghent, Belgium.
  • Kley N; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Uzé G; VIB-UGent Center for Medical Biotechnology, 9052 Ghent, Belgium.
  • Saelens X; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
  • Tavernier J; VIB-UGent Center for Medical Biotechnology, 9052 Ghent, Belgium.
  • Gerlo S; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
NPJ Vaccines ; 5(1): 64, 2020.
Article en En | MEDLINE | ID: mdl-32714571
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2020 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2020 Tipo del documento: Article País de afiliación: Bélgica